Clinical Trial Update: Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Rezvilutamide with radical prostatectomy and metastasis-directed therapy for oligometastatic prostate cancer; currently not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Rezvilutamide (rezvilutamide)

Snippet

Sponsor: Fudan University | Conditions: Oligometastatic Prostate Cancer | Phase 2 | Status: NOT_YET_RECRUITING